α7 Nicotinic receptor agonist-1 (Preparation 5) is an α7 nAChR agonist. It is used in studies of psychiatric disorders such as schizophrenia, manic or hypomanic depression, and anxiety disorders, as well as intellectual disorders including Alzheimer's disease, learning and cognitive deficits, attention deficits, memory loss, Lewy body dementia, and attention deficit hyperactivity disorder.
- Acts as an α7 nAChR agonist
- Suitable for psychiatric disorder research
- Supports intellectual disorder studies
- High purity of 99.7%
- Appearance as a solid
- Light yellow to light brown color
- Molecular formula C13H17N3O
- Soluble in DMSO at 100 mg/mL